Effectiveness of the original trimetazidine MR in patients with stable coronary heart disease and angina attacks resistant to trimetazidine generics (ETALON study)
Aim. To assess the clinical benefits of the original trimetazidine medication (Preductal® MR) in patients with stable coronary heart disease and angina attacks resistant to trimetazidine generics. Material and methods. The study included 112 patients with stable coronary heart disease (CHD), who exp...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
«SILICEA-POLIGRAF» LLC
2011-08-01
|
| Serija: | Кардиоваскулярная терапия и профилактика |
| Teme: | |
| Online pristup: | https://cardiovascular.elpub.ru/jour/article/view/1903 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|